Form 4 for BCPC BALCHEM CORP
Accepted 2024-02-23 00:00:00 ET · period of report 2024-02-21 · accession 0001140361-24-009273 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-23 | 2024-02-21 | BCPC | Sestrick Michael Robert | SVP, CTO | M - OptEx | $78.56 | +11.1K | 17.8K | +165% | +$872.0K |
| D | 2024-02-23 | 2024-02-21 | BCPC | Sestrick Michael Robert | SVP, CTO | S - Sale+OE | $153.21 | -11.1K | 6,736 | -62% | -$1.70M |
| DM | 2024-02-23 | 2024-02-21 | BCPC | Sestrick Michael Robert | SVP, CTO | M - OptEx | $0.00 | -11.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-21 | M | A | 3,500 | $74.57 | 14,136 | D | — | — | (F1) Exercise of fully vested non-qualified stock options. |
| 2 | Common | Common Stock | 2024-02-21 | M | A | 3,900 | $76.89 | 10,636 | D | — | — | (F1) Exercise of fully vested non-qualified stock options. |
| 3 | Common | Common Stock | 2024-02-21 | M | A | 3,700 | $84.09 | 17,836 | D | — | — | (F1) Exercise of fully vested non-qualified stock options. |
| 4 | Common | Common Stock | 2024-02-21 | S | D | 11,100 | $153.21 | 6,736 | D | — | — | (F2) This transaction was executed in multiple sales ranging from $152.7200 to $153.6600 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. |
| 5 | Derivative | Stock Options (right to buy) | 2024-02-21 | M | D | 3,700 | $0.00 | 0 | D | $84.09 · — to 2029-02-13 | 3,700 Common Stock | (F5) Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable. |
| 6 | Derivative | Stock Options (right to buy) | 2024-02-21 | M | D | 3,900 | $0.00 | 0 | D | $76.89 · — to 2027-04-18 | 3,900 Common Stock | (F3) Stock options that vested 20% on April 18, 2018, 40% on April 18, 2019, and 40% on April 18, 2020, and are exercisable. |
| 7 | Derivative | Stock Options (right to buy) | 2024-02-21 | M | D | 3,500 | $0.00 | 0 | D | $74.57 · — to 2028-02-15 | 3,500 Common Stock | (F4) Stock options that vested 20% on February 15, 2019, 40% on February 15, 2020, and 40% on February 15, 2021, and are exercisable. |